Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)
This study has been terminated.
Study NCT00782561   Information provided by FibroGen

First Received on October 27, 2008.   Last Updated on July 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Focal Segmental Glomerulosclerosis
Additional conditions recognized in this trial
Glomerulosclerosis, Focal Segmental
More general conditions related to this trial
Glomerulonephritis
Kidney Diseases
Nephritis
Urologic Diseases
Interventions listed in this trial
FG-3019
Sponsors listed in this trial
FibroGen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services